5
150 J . Org. Chem., Vol. 65, No. 17, 2000
Geraci et al.
1
,5-Ca lix[8]cr ow n -4 5
purification by column chromatography (SiO
cyclohexane) white powder (10%), mp 230-233 °C; H NMR
CDCl
4
: procedure A, entry 2, Table 1,
132.3, 132.7, 142.8, 143.1, 143.7, 147.6, 147.6, 147.9, 148.9,
150.5 (s); FAB(+) MS m/z 1499 (MH) . Anal. Calcd for
98 130
C H O12: C, 78.47; H, 8.73. Found: C 78.55; H, 8.78.
+
2
, gradient AcOEt/
1
(
3
, 295 K) δ 1.24, 1.32, 1.35 (s, 36 H, 18 H, 18 H), 3.65-
.35 (overlapped, 28H), 7.12 (d, 8 H, J ) 1.5 Hz), 7.22, 7.29 (s,
H each), 8.99, 9.65 (br s, 4 H, 2 H); C NMR (CDCl , 295 K)
3
δ 26.8, 32.9 (t), 31.4, 31.5, 31.6 (q), 34.0, 34.3 (s), 70.4, 71.9,
5.1 (t), 125.0, 125.5, 126.2, 126.6 (d), 127.1, 127.2, 127.3,
33.1, 143.0, 143.5, 147.9, 148.3, 148.6, 150.1 (s); FAB(+) MS
m/z 1411 (MH) . Anal. Calcd for C94
Found: C, 79.80; H, 8.68.
4
Hexa m eth oxy-1,4-ca lix[8]cr ow n -4 4 a . A mixture of 1,4-
calix[8]crown-4 (70 mg, 0.050 mmol) and NaH (38 mg, 1.6
mmol) in anhydrous THF (30 mL) was refluxed under stirring
4
4
1
3
3
for 30 min. CH I (0.1 mL, 1.6 mmol) was then added, and the
7
1
reaction mixture was refluxed for 30 h. Evaporation under
vacuum left a residue that was suspended in 1 N HCl, collected
by filtration, dried, and purified by column chromatography
+
122
H O10: C, 79.96; H, 8.71.
(
SiO
2
, increasing concentrations of AcOEt in cyclohexane as
a (40 mg, 53%): white powder,
, 295 K) δ 1.06, 1.07, 1.11,
.32 (s, 18 H each), 2.76 (br s, 4 H), 2.80, 2.95 (br t, 4 H each),
.43, 3.54, 3.72 (s, 6 H each), 4.00, 4.03 (br s, 4 H, 12 H), 6.69
1
,5-Ca lix[8]cr ow n -2 5
white powder (88%), purification by column chromatography
SiO , gradient AcOEt/petroleum ether), mp > 280 °C (dec);
H NMR (CDCl , 330 K) δ 1.11, 1.25, 1.33, (s, 18, 18, 36 H),
.81, 3.89 (br s, 8 H each), 5.20 (br s, 4 H), 6.96, 7.12 (s, 4 H
each), 7.17 and 7.19 (AB system, 8 H, J ) 1.5 Hz), 8.62, 8.99
2
: procedure C, entry 3, Table 1,
the eluting system) to give 4
4
1
mp 142-144 °C; H NMR (CDCl
1
3
3
(
2
1
3
3
(
)
7
d, 2 H, J ) 2.2 Hz), 6.82 (d, 2 H, J ) 2.2 Hz), 6.87 (d, 2 H, J
2.3 Hz), 6.98 (d, 2 H, J ) 2.2 Hz), 7.04 (d, 2 H, J ) 2.3 Hz),
.09 (d, 2 H, J ) 2.3 Hz), 7.12 (d, 2 H, J ) 2.4 Hz), 7.22 (d, 2
1
3
(
s, 4 H, 2 H); C NMR (CDCl
2.3 (t), 34.0, (s), 70.9 (t), 125.7, 126.5, (d), 127.3, 128.2, 133.0,
43.4, 149.0, 151.6, 152.6 (s); FAB(+) MS m/z 1345 (MNa) .
Anal. Calcd for C90
H, 8.72.
3
, 330 K) δ 31.1, 31.5, 31.7 (q),
3
1
+
H, J ) 2.4 Hz); FAB(+) MS m/z 1495 (MH) . Anal. Calcd for
C
+
100
H
134
O
10: C, 80.28, H, 9.03. Found: C, 80.06; H 9.00.
Gen er a l P r oced u r e for Ben zyla tion of Ca lix[8]cr ow n s.
CO (400 mg, 1.23 mmol) was added to a suspension of the
CO (30
114 8
H O : C, 81.71; H, 8.68. Found: C, 81.35;
Cs
2
3
1
,5-Ca lix[8]cr ow n -3 5
3
: procedure C, entry 4, Table 1,
calix[8]crown-4 of choice (50 mg, 0.035 mmol) in Me
2
white powder (78%), purification by column chromatography
mL), and the mixture was stirred under reflux for 20 min.
Then, a solution of 4-(tert-butyl)benzyl bromide (0.052 mL,
1
(
SiO
2
, gradient AcOEt/cyclohexane), mp > 280 °C (dec); H
, 330 K) δ 1.12, 1.29, 1.31, (s, 18, 36, 18 H), 3.83
br s, 8 H), 3.95, 4.27 (br t, 4 H each), 4.67 (br s, 8 H), 7.00 (s,
NMR (CDCl
3
0
2
.283 mmol) in Me CO (2 mL) was added, and stirring was
(
4
maintained under reflux for 22 h. The solvent was evaporated
under vacuum, and the residue was suspended in 1 N HCl
H), 7.09, 7.17 (AB system, 4 H each, J ) 2.2 Hz) 7.21 (s, 4
H), 7.17 and 7.19 (AB system, 8 H, J ) 1.5 Hz), 8.57, 8.65 (s,
(
50 mL), collected by filtration, dried, and purified by prepara-
tive TLC (silica gel plates Kieselgel 60 F254, 1 mm, Merck, CH
Cl /petroleum ether 7:13).
H exa k is(p -ter t-b u t ylb en zyl)-1,2-ca lix[8]cr ow n -4 2
1
3
2
3
1
1
3
H, 4 H); C NMR (CDCl , 295 K) δ 31.2, 32.4 (t), 31.5 (q),
2
-
3.9, 34.2 (s), 69.7, 74.7 (t), 125.3, 125.4, 125.9, 127.0 (d), 143.1,
2
43.8, 147.7, 148.1, 148.1, 148.9, 149.4 (s); FAB(+) MS m/z
367 (MH) . Anal. Calcd for C92
+
4
b :
, 325
K) δ 0.90, 0.97, 1.06, 1.15, 1.25, 1.29, 1.31 (s, 18 H each), 2.76
br s, 8 H), 3.15 (br t, 4 H), 4.01, 4.06, 4.12, 4.13, 4.14 (s, 2 H,
2 H, 4 H, 4 H, 4 H), 4.64, 4.76, 4.82 (s, 4 H each), 6.7-7.6
overlapped, 40 H); 13C NMR (CDCl
, 295 K) δ 28.2, 29.1, 29.7,
0.7 (t), 31.4 (q), 34.1, 34.4 (s), 69.3, 70.4, 72.3, 74.5, 74.8, 77.2
t), 125.2, 125.7, 126.3, 127.1, 127.3, 128.1(d), 132.3, 133.1,
33.3, 133.4, 133.42, 133.6, 133.7, 134.7, 145.1, 145.9, 146.3,
150.5, 150.6, 152.5, 152.7, 152.8, 153.3 (s); FAB(+) MS m/z
118 9
H O : C, 80.78; H, 8.69.
1
white powder (42%), mp 158-162 °C; H NMR (CDCl
3
Found: C, 80.55; H, 8.62.
,4-Ca lix[8]cr ow n -4 4
purification by column chromatography (SiO
cyclohexane) white powder (46%), mp 229-232 °C; H NMR
CD CO, 295 K) δ 1.17, 1.97, 1.22, 1.25 (s, 18 H each), 3.70-
1
4
: procedure B, entry 7, Table 1,
, gradient AcOEt/
(
2
1
(
3
(
1
3
(
3 2
)
4
.10 (overlapped, 28 H), 7.06 (d, 2 H, J ) 2,2 Hz), 7.12 (d, 2 H,
J ) 2.2 Hz), 7.16 (d, 2 H, J ) 2.4 Hz), 7.18 (d, 2 H, J ) 2.3
Hz), 7.28 (d, 2 H, J ) 2.0 Hz), 7.30 (d, 2 H, J ) 2.5 Hz), 7.34
1
(
d, 2 H, J ) 2.3 Hz), 8.35, 8.85, 9.05 (br s, 2 H each); H NMR
+
2
287 (MH) . Anal. Calcd for C160
Found: C, 83.70; H 9.10.
H exa k is(p -ter t-b u t ylb en zyl)-1,3-ca lix[8]cr ow n -4 3 b :
206
H O10: C, 83.94; H, 9.07.
(C
6
D
6
, 307 K) δ 1.20, 1.25 (s, 18 H each), 1.26, (s, 36 H), 3.82,
3
4
3
7
.85, 3.87 (br s, 4 H, 2 H, 6 H), 3.97, 4.04, 4.08 (br s, 8 H, 4 H,
1
3
H), 7.10-7.30 (overlapped, 16 H); C NMR (C
0.5, 31.2, 32.4, 32.6, 32.8 (t), 31.5, 31.8 (q), 34.1, 34.4 (s), 70.5,
1.5, 75.1 (t), 125.1, 125.7, 126.0, 126.3, 126.6, 127.0, 128.3
6
D
6
, 307 K) δ
4
1
white powder (72%), mp > 280 °C (dec); H NMR (CDCl
K) δ 0.70, 0.86, 1.00, 1.19, 1.26, 1.31, 1.32, 1.35, 1.37 (s, 9 H,
H, 18 H, 18 H, 18 H, 9 H, 9 H, 18 H, 18 H), 2.40, 2.61, 2.65,
2.77 (m, 12 H), 3.67 and 4.64 (AX system, 4 H, J ) 16.6 Hz),
.68 and 4.67 (AX system, 4 H, J ) 16.6 Hz), 3.78 and 4.74
3
, 320
9
(
1
d), 129.1, 133.4, 133.6, 143.0, 143.4, 144.0, 147.9, 148.5, 149.3,
+
49.7, 151.5 (s); FAB(+) MS 1411 (MH) . Anal. Calcd for
10: C, 79.96; H; 8.71. Found: C, 79.89, H, 8.62.
,4-Ca lix[8]cr ow n -5 4 : procedure B, entry 8, Table 1,
purification by column chromatography (SiO , gradient AcOEt/
cyclohexane), white powder (31%), mp 197-199 °C; H NMR
CDCl , 306 K) δ 1.24, 1.28, 1.32, 1.34 (s, 18 H each), 3.84 (br
s, 8 H), 3.91, 3.94 (s, 2 H each), 3.95, 4.01, 4.11 (s, 4 H each),
3
(
94 122
C H O
1
AX system, 4 H, J ) 15.1 Hz), 4.00 and 4.40 (AB system, 4
5
H, J ) 16.1), 4.98, 5.03 (s, 12 H), 6.59 (s, 2 H), 6.66 (s, 2 H),
2
1
6.80 and 7.07 (AX system, 4 H, J ) 2.0 Hz), 7.04 (d, 2 H, J )
2
.2 Hz), 7.10-7.60 (overlapped, 30 H); 13C NMR (CDCl
, 295
3
(
3
K) δ 29.2, 29.9, 30.1 (t), 31.4, 31.5 (q), 34.0, 34.3, 34.5, 34.6
(
s), 68.8, 72.9, 73.2, 74.0, 74.7 (t), 122.7, 123.6, 123.8, 124.6,
4
2
2
8
3
7
1
1
.13, 4.36 (br t, 4 H each), 7.06 (d, 2 H, J ) 2.2 Hz), 7.14 (d,
H, J ) 2.3 Hz), 7.17 (d, 4 H, J ) 2.1 Hz), 7.20 (d, 4 H, J )
.3 Hz), 7.21 (d, 2 H, J ) 2.4 Hz), 7.23 (d, 2 H, J ) 2.4 Hz),
1
1
25.2, 125.3, 127.1, 127.5, 127.6, 127.8, 128.0, 128.2, 128.8 (d),
31.5, 132.5, 132.7, 133.0, 133.5, 134.0, 134.1, 134.3, 134.7,
.20, 9.04, 9.73 (br s, 2 H each); 13C NMR (CDCl3, 306 K) δ
135.3, 145.3, 145.5, 146.0, 146.1, 146.2, 150.7, 150.8, 151.9,
+
1
52.7, 152.8, 153.0, 154.3 (s); FAB(+) MS m/z 2287 (MH) .
0.6, 30.9, 31.7, 31.9, 32.8 (t), 31.3, 31.6 (q), 34.0, 34.3 (s) 70.1,
1.0, 71.5, 74.9 (t), 125.3, 125.7, 125.9, 126.2, 126.3, 126.4 (d),
26.5, 126.9, 127.1, 127.4, 127.7, 132.4, 132.9, 142.9, 143.0,
Anal. Calcd for C160
H 9.01.
206
H O10: C, 83.94; H, 9.07. Found: C 83.81,
43.7, 147.9, 148.0, 148.8, 150.2 (s); FAB(+) MS m/z 1455
MH) . Anal. Calcd for C96
C, 79.30, H, 8.73.
H exa k is(p -ter t-b u t ylb en zyl)-1,4-ca lix[8]cr ow n -4 4
4
b :
+
1
(
H
126
O
11: C, 79.18; H, 8.72. Found:
white powder (43%), mp 164-168 °C; H NMR (CDCl
3
, 324
K) δ 0.97, 1.06, 1.09, 1.26, 1.32, 1.33, 1.36 (s, 18 H each), 2.05,
2.24, 2.28, 2.36 (m, 2 H each), 2.73 (br t, 4 H), 3.42 and 4.96
(AX system, 2 H, J ) 14.4 Hz), 3.67 and 4.47 (AX system, 4 H
J ) 17.1 Hz), 3.75 and 4.45 (AX system, 4 H, J ) 16.5 Hz),
3.93 and 4.30 (AB system, 2 H, J ) 15.4 Hz), 4.60 and 4.68
(AB system, 4 H, J ) 11.2 Hz), 4.87, 4.89, 4.76 (s, 4 H each),
1
,4-Ca lix[8]cr ow n -6 4
6
: procedure B, entry 9, Table 1,
, gradient AcOEt/
cyclohexane), white powder (25%); H NMR (CDCl , 293 K) δ
.18, 1.23, 1.27, 1.28 (s, 18 H each), 3.69 (br s, 4 H), 3.77, 3.83
purification by column chromatography (SiO
2
1
3
1
(
(
m, 4 H each), 3.86, 3.90, 4.00, 4.10 (br s, 4 H each), 4.11, 4.26
m, 4 H each), 7.00 (d, 2 H, J ) 1.9 Hz), 7.08 (d, 2 H, J ) 2.5
6.5-7.5 (overlapped, 40 H); 13C NMR (CDCl
, 295 K) δ 27.6,
3
Hz), 7.14-7.23 (overlapped, 12 H), 8.36, 9.14, 9.83 (br s, 2 H
29.1, 30.3 (t), 31.4, 31.6 (q), 34.06, 34.1, 34.2, 34.4, 34.5 (s),
69.1, 72.3, 74.5, 74.3 (t), 123.8, 125.0, 125.2, 125.3, 125.6, 125.9,
127.8, 128.1, 128.2 (d), 132.0, 132.1, 132.6, 133.1, 133.6, 134.0,
134.4, 134.5, 134.8, 145.3, 145.9, 150.1, 150.5, 150.7, 152.2,
1
3
each); C NMR (CDCl
3
, 306 K) δ 30.7, 31.2, 32.7 (t), 31.3, 31.5
(
1
q), 34.0, 34.3 (s), 70.7, 70.8, 71.8, 75,0 (t), 125.2, 125.6, 125.7,
25.9, 126.2, 126.4 (d), 126.6, 126.9, 127.1, 127.3, 127.6, 128.7,